Metabolic biomarkers differentiate extrapulmonary tuberculosis from pulmonary TB and non-TB pleural effusions - Takeaways - MDSpire

Metabolic biomarkers differentiate extrapulmonary tuberculosis from pulmonary TB and non-TB pleural effusions

  • By

  • Holly May-Lewis

  • Michael James Perret

  • Ye Xu

  • Roberto Stefan Almeida Ribeiro

  • Raquel da Silva Correa

  • Thiago Thomaz Mafort

  • Ana Paula Santos

  • Rogério Rufino

  • Luciana Rodrigues

  • Khushboo Borah Slater

  • June 11, 2026

  • 0 min

Share

  • 1

    Extrapulmonary tuberculosis (TB) pleural effusion (PlTB) is difficult to diagnose due to overlapping symptoms with non-TB pleural effusions.

  • 2

    High-throughput targeted metabolomics identified taurine, glycine, tryptophan, and kynurenine as key metabolites for differentiating PlTB from other conditions.

  • 3

    Current diagnostic methods for PlTB, like culture and staining, have low sensitivity, necessitating the search for new biomarkers.

  • 4

    This study analyzed samples from 58 individuals to uncover metabolic signatures that can accurately distinguish PlTB from pulmonary TB and non-TB effusions.

  • 5

    The findings suggest that novel metabolic biomarkers could significantly enhance the clinical diagnosis of PlTB, improving treatment outcomes.

Original Source(s)

Related Content